Vaccine-boosted CAR T crosstalk with host immunity to reject tumors with antigen heterogeneity
Leyuan Ma(Children's Hospital of Philadelphia), Darrell J. Irvine(Howard Hughes Medical Institute)
Cited by 198
Related Papers
Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery
|Nature Biotechnology|2018|641
Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses
|Nature Medicine|2016|536
Controlling timing and location in vaccines
|Advanced Drug Delivery Reviews|2020|260
Targeted modulation of immune cells and tissues using engineered biomaterials
|Nature Reviews Bioengineering|2023|147